CVS Health Pharmacy — Revenues from external customers increased by 3.5% to $61.62B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.6%, from $56.24B to $61.62B. Over 4 years (FY 2021 to FY 2025), Pharmacy — Revenues from external customers shows an upward trend with a 5.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests growth in prescription volume, higher drug pricing, or successful expansion of pharmacy service offerings, while a decrease may indicate competitive pressure, changes in reimbursement rates, or shifts in patient utilization.
This metric represents the total gross revenue generated by the pharmacy services segment from transactions with third-p...
Comparable to net sales or segment revenue reported by other large-scale pharmacy retailers and pharmacy benefit managers, though variations exist based on how companies account for rebates and pass-through costs.
cvs_segment_pharmacy_revenues_from_external_customers| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.93B | $47.03B | $48.70B | $47.49B | $51.33B | $52.38B | $53.93B | $52.50B | $55.06B | $56.20B | $59.69B | $48.40B | $50.98B | $54.66B | $56.24B | $52.51B | $55.35B | $59.55B | $61.62B |
| QoQ Change | — | +2.4% | +3.5% | -2.5% | +8.1% | +2.0% | +3.0% | -2.7% | +4.9% | +2.1% | +6.2% | -18.9% | +5.3% | +7.2% | +2.9% | -6.6% | +5.4% | +7.6% | +3.5% |
| YoY Change | — | — | — | — | +11.7% | +11.4% | +10.7% | +10.5% | +7.3% | +7.3% | +10.7% | -7.8% | -7.4% | -2.7% | -5.8% | +8.5% | +8.6% | +8.9% | +9.6% |